Voltamp Transformers Q1 FY27 Results Analysis: Revenue Surges 28%, Margin Compresses 238 bps
Cofacto Research
Updated July 31, 2026
2 min read
Neutral
Voltamp Transformers Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 543.78 Cr (+28.38% YoY) and PAT growth of +14.68% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | July 31, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 543.78 Cr (+28.38% YoY) |
|---|
| PAT (Q1) | Rs. 91.22 Cr (+14.68% YoY) |
|---|
| EBITDA margin | 14.77% (-238 bps YoY) |
|---|
| EPS (Q1) | Rs. 90.17 (+14.68% YoY) |
|---|
| Market cap | Rs. 10,038.74 Cr |
|---|
| CMP | Rs. 9,923.00 |
|---|
Quarter Snapshot
Voltamp delivered strong revenue growth of 28% YoY, driven by 100%+ capacity utilization, but margin compression of 238 bps from raw material cost pressure offset earnings growth. The board's Rs.90 crore capex for 2,300 MVA capacity expansion signals confidence in sustained demand, though near-term margin headwinds from commodity costs remain a concern.
Key Investment Insights
Key Positives
- Revenue grew 28.38% YoY to Rs.543.78 crore, the strongest top-line growth in recent quarters.
- EBITDA grew 10.54% YoY to Rs.80.30 crore, with QoQ margin improvement from 13.18% to 14.77%.
- PAT grew 14.68% YoY to Rs.91.22 crore, and basic EPS was Rs.90.17.
- Board approved Rs.90 crore capex for 2,300 MVA capacity expansion, funded through internal accruals, within 12-14 months.
- Capacity utilization at 100% plus, validating strong demand.
- Effective tax rate improved to 22.62% from 23.98% a year ago.
Risk Factors
- EBITDA margin compressed 238 bps YoY to 14.77% from 17.15%, due to cost growth outpacing revenue.
- Cost of materials grew 41.85% YoY, far exceeding revenue growth of 28.38%, indicating raw material cost pressure.
- Total expenses grew 31.83% YoY, outpacing revenue growth of 28.38%.
- PAT growth of 14.68% lagged revenue growth of 28.38%, reflecting margin compression.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now